Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerio Izzi

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
Matrix Biology Plus|February 5, 2021
Pan-Cancer analysis of the expression and regulation of matrisome genes across 32 tumor typesValerio Izzi, Juho Lakkala, Raman Devarajan, et al.
Peptides|October 12, 2010
Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophagesValerio Chiurchiù, Valerio Izzi, Fabiola D'Aquilio, et al.
International Journal of Molecular Sciences|December 3, 2020
Machine Learning Identifies Robust Matrisome Markers and Regulatory Mechanisms in CancerAnni Kääriäinen, Vilma Pesola, Annalena Dittmann, et al.
International Journal of Oncology|January 17, 2009
Differential effects of malignant mesothelioma cells on THP-1 monocytes and macrophagesValerio Izzi, Valerio Chiurchiù, Fabiola D'Aquilio, et al.
Leukemia Research Reports|December 23, 2017
Expression of a specific extracellular matrix signature is a favorable prognostic factor in acute myeloid leukemiaValerio Izzi, Juho Lakkala, Raman Devarajan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 27, 2021
Genetic Ablation of Transmembrane Prolyl 4-Hydroxylase Reduces Atherosclerotic Plaques in MiceJenni Määttä, Raisa Serpi, Sohvi Hörkkö, et al.
American Journal of Hematology|October 4, 2017
Vanin 1 (VNN1) levels predict poor outcome in acute myeloid leukemiaValerio Izzi, Juho Lakkala, Raman Devarajan, et al.
The Journal of Biological Chemistry|April 18, 2026
P4HA3 is dispensable for prolyl 4-hydroxylation of type I collagen during mouse developmentEmma Karjalainen, Pekka Rappu, Valerio Izzi, et al.
Cancers|April 3, 2021
The Burden of Post-Translational Modification (PTM)-Disrupting Mutations in the Tumor MatrisomeElisa Holstein, Annalena Dittmann, Anni Kääriäinen, et al.
Journal of Cellular and Molecular Medicine|April 6, 2026
OMICS Profiling Identifies Signatures of Senescence in Osteogenesis Imperfecta Osteoblasts Counteracted by 4-PBARoberta Besio, Elisa Maffioli, Erika Palladino, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Matrix Biology Plus|February 5, 2021
Pan-Cancer analysis of the expression and regulation of matrisome genes across 32 tumor typesValerio Izzi, Juho Lakkala, Raman Devarajan, et al.
Peptides|October 12, 2010
Endomorphin-1 prevents lipid accumulation via CD36 down-regulation and modulates cytokines release from human lipid-laden macrophagesValerio Chiurchiù, Valerio Izzi, Fabiola D'Aquilio, et al.
International Journal of Molecular Sciences|December 3, 2020
Machine Learning Identifies Robust Matrisome Markers and Regulatory Mechanisms in CancerAnni Kääriäinen, Vilma Pesola, Annalena Dittmann, et al.
International Journal of Oncology|January 17, 2009
Differential effects of malignant mesothelioma cells on THP-1 monocytes and macrophagesValerio Izzi, Valerio Chiurchiù, Fabiola D'Aquilio, et al.
Leukemia Research Reports|December 23, 2017
Expression of a specific extracellular matrix signature is a favorable prognostic factor in acute myeloid leukemiaValerio Izzi, Juho Lakkala, Raman Devarajan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 27, 2021
Genetic Ablation of Transmembrane Prolyl 4-Hydroxylase Reduces Atherosclerotic Plaques in MiceJenni Määttä, Raisa Serpi, Sohvi Hörkkö, et al.
American Journal of Hematology|October 4, 2017
Vanin 1 (VNN1) levels predict poor outcome in acute myeloid leukemiaValerio Izzi, Juho Lakkala, Raman Devarajan, et al.
The Journal of Biological Chemistry|April 18, 2026
P4HA3 is dispensable for prolyl 4-hydroxylation of type I collagen during mouse developmentEmma Karjalainen, Pekka Rappu, Valerio Izzi, et al.
Cancers|April 3, 2021
The Burden of Post-Translational Modification (PTM)-Disrupting Mutations in the Tumor MatrisomeElisa Holstein, Annalena Dittmann, Anni Kääriäinen, et al.
Journal of Cellular and Molecular Medicine|April 6, 2026
OMICS Profiling Identifies Signatures of Senescence in Osteogenesis Imperfecta Osteoblasts Counteracted by 4-PBARoberta Besio, Elisa Maffioli, Erika Palladino, et al.
Pageof 7